RA
CLX icon

Royce & Associates’s Clorox CLX Stock Holding History

Royce & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+3,978
New +$382K ﹤0.01% 719

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royce & Associates's CLX Position: Q2 2026 in Review

Royce & Associates opened a new position in Clorox (CLX) in Q2 2026: 3,978 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #719 among its holdings.

1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Royce & Associates held 3,978 shares of Clorox worth $380K as of Q2 2026.
  • Clorox was a new Royce & Associates position in Q2 2026.
  • Clorox made up ﹤0.01% of Royce & Associates's portfolio in Q2 2026, its #719 holding.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.